Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 825 of 1467 entries
View as:

EValuating trEatment RESponses of Dupilumab Versus Omalizumab in Type 2 Patients

Phase: N/A Priority: Normal
NCT ID: NCT04998604 Org: User:
Start: 09/27/21 End: 12/27/24 Due: 12/27/25

Evaluation of AVE5026 as Compared to Enoxaparin for the Prevention of Thromboembolism in Patients Undergoing Total Hip Replacement Surgery

Phase: N/A Priority: Normal
NCT ID: NCT00697099 Org: User:
Start: 06/30/08 End: 06/30/09 Due: 06/30/10

Efficacy and Safety Study of NV1FGF in Patients With Severe Peripheral Artery Occlusive Disease.

Phase: N/A Priority: Normal
NCT ID: NCT00798005 Org: User:
Start: 06/30/02 End: 07/31/05 Due: 07/31/06

Efficacy and Safety of Lixisenatide Versus Insulin Glulisine on Top of Insulin Glargine With or Without Metformin in Type 2 Diabetic Patients

Phase: N/A Priority: Normal
NCT ID: NCT01768559 Org: User:
Start: 01/31/13 End: 12/31/14 Due: 12/31/15

Post-marketing Surveillance Study for the Safety of Efluelda Tetra Pre-filled Syringe.

Phase: N/A Priority: Normal
NCT ID: NCT06694025 Org: User:
Start: 10/01/25 End: 12/05/30 Due: 12/05/31

A Study to Evaluate Pharmacokinetic Parameters of Eliglustat in Healthy Volunteers Who Are CYP2D6 Extensive or Poor Metabolizers

Phase: N/A Priority: Normal
NCT ID: NCT06188325 Org: User:
Start: 01/01/18 End: 03/26/18 Due: 03/26/19

A Study to Evaluate the Effect of Food on the Pharmacokinetics of Sotagliflozin and to Explore the Relative Bioavailability in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT03174548 Org: User:
Start: 06/12/17 End: 09/15/17 Due: 09/15/18

Efficacy and Safety of M100907 on Sleep Maintenance Insomnia With a Sub-study in Stable Type II Diabetes Mellitus

Phase: N/A Priority: Normal
NCT ID: NCT00495885 Org: User:
Start: 06/30/07 End: 10/31/08 Due: 10/31/09

ODYSSEY Outcomes: Evaluation of Cardiovascular Outcomes After an Acute Coronary Syndrome During Treatment With Alirocumab

Phase: N/A Priority: Normal
NCT ID: NCT01663402 Org: User:
Start: 10/31/12 End: 01/23/18 Due: 01/23/19

Study of the Efficacy and Safety of Ferrlecit in the Maintenance Dosing in Hemodialysis Patients.

Phase: N/A Priority: Normal
NCT ID: NCT00223938 Org: User:
Start: 12/30/03 End: 04/27/07 Due: 04/27/08

Dupilumab Effect on Pruritus Neuro-mechanisms in Patients With Atopic Dermatitis

Phase: N/A Priority: Normal
NCT ID: NCT04823130 Org: User:
Start: 04/22/21 End: 08/30/22 Due: 08/30/23

Evaluation of Effect of Alirocumab on Coronary Atheroma Volume in Japanese Patients Hospitalized for Acute Coronary Syndrome With Hypercholesterolemia

Phase: N/A Priority: Normal
NCT ID: NCT02984982 Org: User:
Start: 11/15/16 End: 07/27/18 Due: 07/27/19

Study of a Combination Vaccine Comprised of Different Recombinant Spike Antigen Levels of a Matrix-M Adjuvanted Recombinant COVID-19 Vaccine and High-Dose Inactivated Influenza Vaccine in Adult Participants 50 Years of Age and Older

Phase: N/A Priority: Normal
NCT ID: NCT06695117 Org: User:
Start: 11/19/24 End: 04/01/26 Due: 04/01/27

Telithromycin in Respiratory Tract Infections

Phase: N/A Priority: Normal
NCT ID: NCT00261105 Org: User:
Start: 02/28/05 End: 12/31/05 Due: 12/31/06

Clinical Trial in Males With BPH (Enlarged Prostate)

Phase: N/A Priority: Normal
NCT ID: NCT00029822 Org: User:
Start: 05/31/01 End: 03/31/05 Due: 03/31/06

Two Regimens of SAR240550/Weekly Paclitaxel and Paclitaxel Alone as Neoadjuvant Therapy in Triple Negative Breast Cancer Patients

Phase: N/A Priority: Normal
NCT ID: NCT01204125 Org: User:
Start: 09/30/10 End: 02/28/17 Due: 02/28/18

Trial of Ombrabulin (AVE8062) in Combination With Taxane and Platinum in Patients With Non-small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01263886 Org: User:
Start: 02/28/11 End: 10/31/12 Due: 10/31/13

A Study of Meningococcal Vaccine, Menactra® in Healthy Subjects in India

Phase: N/A Priority: Normal
NCT ID: NCT01086969 Org: User:
Start: 06/30/10 End: 06/30/11 Due: 06/30/12

Effects of Lixisenatide Compared to Liraglutide on the Postprandial Plasma Glucose in Patients With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT01175473 Org: User:
Start: 08/31/10 End: 11/30/10 Due: 11/30/11

Pulmonart: Docetaxel - Non-Small Cell Lung Cancer (NSCLC)

Phase: N/A Priority: Normal
NCT ID: NCT00174772 Org: User:
Start: 03/31/04 End: 02/28/09 Due: 02/28/10

A Study of SAR444245 Combined With Other Anticancer Therapies for the Treatment of Participants With HNSCC (Master Protocol) (Pegathor Head and Neck 204)

Phase: N/A Priority: Normal
NCT ID: NCT05061420 Org: User:
Start: 10/08/21 End: 11/26/24 Due: 11/26/25

Assessment of the Safety and Efficacy of Dupilumab in Children With Asthma (Liberty Asthma Excursion)

Phase: N/A Priority: Normal
NCT ID: NCT03560466 Org: User:
Start: 06/21/18 End: 04/01/25 Due: 04/01/26

Dermacyd Breeze Pocket BR (Lactic Acid) - Acceptability

Phase: N/A Priority: Normal
NCT ID: NCT00793026 Org: User:
Start: 11/30/08 End: - Due: -

Evaluation of Paclitaxel (Taxol, NSC #673089), Carboplatin (Paraplatin, NSC #241240), and BSI-201 (NSC #746045, IND #71,677) in the Treatment of Advanced, Persistent, or Recurrent Uterine Carcinosarcoma

Phase: N/A Priority: Normal
NCT ID: NCT00687687 Org: User:
Start: 05/31/08 End: 12/31/11 Due: 12/31/12

POWER Point of Care Effect on Satisfaction of Treatment

Phase: N/A Priority: Normal
NCT ID: NCT00549068 Org: User:
Start: 02/28/03 End: 11/30/04 Due: 11/30/05